Contraindications and Interactions: Model Integration and

Data Characteristics

Contraindication and interaction data primarily originates from drug inserts, pharmacopoeias, clinical guidelines, and specialized drug databases. This data updates frequently, especially with new drug approvals or clinical evidence. Information is added promptly. Data typically exists in structured or semi-structured formats like XML, JSON, or tables. Core fields include drug name (generic, brand), active ingredients, interaction type (drug-drug, drug-food, drug-disease), interaction mechanism, clinical manifestations, risk level, and management recommendations. Units commonly include milligrams (mg), grams (g), and milliliters (ml) for dosage. Frequency is described as once daily, twice daily, etc. Time units like hours (h) and days (d) are also common.

Constraints Imposed by Data Characteristics on "Model Integration and Configuration"

The high update frequency of contraindication and interaction data requires an efficient synchronization mechanism for the knowledge base to ensure timely query results. Structured data sources facilitate precise field mapping and index construction, reducing model comprehension difficulty and improving recall accuracy. The model must accurately identify and extract critical information like risk levels and management recommendations to avoid misleading outputs. Specialized terminology and abbreviations, such as CYP450 enzymes and QT interval prolongation, demand strong domain vocabulary understanding from the model. Furthermore, the complexity of interactions, such as cascading effects from multiple drug combinations, places higher demands on the model's reasoning and context management capabilities. The maxContext parameter setting is particularly crucial.

Configuration Guidelines

Configuration Item	Recommended Value	Rationale
`maxContext`	`8000 tokens`	Must cover complex interaction pathways and detailed descriptions for multiple drug combinations.
`Chunk size` (Segment Length)	`500 characters` (characters)	Ensures a single segment contains a complete interaction description and recommendation.
`Recall count` (Recall Count)	`8-12 entries` (items)	Increases the possibility of covering potential interactions, avoiding omissions.
`Similarity threshold` (Similarity Threshold)	Calibrated by measurement	Balances recall and precision, avoiding irrelevant information interference.
`Rerank result count` (Reranked Return Count)	`5 entries` (items)	Focuses on the most relevant interactions, reducing user reading burden.
`ENABLE_RERANKER`	`true`	Improves the quality of recall results, prioritizing the most important information.

Common Pitfalls

Query results lack some drug interaction information. This might be due to outdated knowledge base data synchronization or a segmentation strategy truncating critical information.
Model responses provide vague risk warnings without specific dosage or interaction mechanisms. This could be because the model failed to accurately extract core fields from the data or the prompt template lacked specific guidance.
When integrating a custom local model, the Protocol Type field does not allow selecting the required type, preventing successful model registration. This happens when the platform's built-in protocol types do not support the model's API specification.

Verification Steps

Query known drug combinations with interactions. Verify if the model's response includes the corresponding interaction type, risk level, and management recommendations.
Randomly select frequently updated data from the knowledge base. Check its latest status in FastGPT to confirm the data synchronization mechanism is functioning correctly.
Test with questions containing specialized terminology and abbreviations. Evaluate the model's understanding of domain vocabulary by comparing it with the original data.
Check FastGPT backend logs for warnings like context window exceeded during complex queries. Adjust the maxContext parameter accordingly.

Note: The values provided are common starting points. Measure performance against specific samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.